Shunrenka tablets 300mg contain Lenacapavir Sodium, a first-in-class capsid inhibitor developed by Gilead Sciences for the treatment of HIV-1 infection in heavily treatment-experienced adults. (YJ code: 6250053F1028, standard: 300mg 1 tablet)
Shunrenka tablets 300mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
More from this manufacturer
